In addition to TCGA, we examined GLO expression in other published NSCLC proteomic studies16,17 and observed similar effects as in our study: compared to healthy tissue, both GLO1 and GLO2 were prominently downregulated, while hypoxic targets were all upregulated in tumor (Fig. 4E). The gene discussed is GLO1; the disease is non-small cell lung carcinoma.